Novavax expects FDA clearance as early as Might
The Food and Drug Administration could approve Novavax's Covid-19 vaccine for emergencies as early as May, the company's CEO Stanley Erck told CNBC on Monday.Novavax's Phase 3 trial in the US with 30,000 participants is ongoing, Erck said.…